| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Cyclosporine | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Tacrolimus | FAERS: 8 | US FAERS | |
| 3 | Lenalidomide | FAERS: 7 | US FAERS | |
| 4 | Azacitidine | FAERS: 2 | US FAERS | |
| 5 | Bortezomib | FAERS: 2 | US FAERS | |
| 6 | Deferasirox | FAERS: 2 | US FAERS | |
| 7 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 8 | Clofarabine | FAERS: 1 | US FAERS | |
| 9 | Decitabine | FAERS: 1 | US FAERS | |
| 10 | Prednisone | FAERS: 1 | US FAERS | |
| 11 | Rifampin | FAERS: 1 | US FAERS | |
| 12 | posaconazole | FAERS: 1 | US FAERS | |
| 13 | romidepsin | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.